Study of Renal Blood Flow During Human Endotoxemia
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of the present protocol is to study whether endotoxemia will affect the renal blood flow in type 2 diabetics and healthy volunteers.
Full description
Many septic patients develop acute renal failure and the risk is higher in patients with diabetes. The pathogenetic mechanisms behind the development of acute renal failure in connection with sepsis is not completely understood. One among many possible explanations is a change in renal hemodynamics. However, it is still largely unknown what happens to the renal plasma flow during human sepsis. In this study we give endotoxin injection (0,3 ng/kg) to type 2 diabetics and healthy controls as an experimental model of sepsis. Renal plasma flow and glomerular filtration rate are measured by DTPA-renography 1 day before before and 1,25 and 6,5 hours after injection of endotoxin. Furthermore WBC, plasma-cytokines,VCAM-1/ICAM-1, endothelin-1, Thromboxane B2, angiotensin 2, renin and PAI-1 are measured on an hourly basis up to 8 hours after endotoxin injection.
Sex
Ages
Volunteers
Inclusion criteria
- Healthy
- Type 2 diabetes
Exclusion criteria
- Renal failure
- Heart failure
- Lung disease
Trial design
Primary purpose
Allocation
Interventional model
Masking
Trial contacts and locations
Loading...
Central trial contact
Anne Sofie Andreasen, MD; Bente K Pedersen, Professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal